arXiv preprint ·

Learning Who Benefits Most: Multi-Treatment Causal Ranking for Population Health Stratification

Rocco Zaccagnino, Martina Girolamo, Alberto Lombardi, Delfina Malandrino, Donatello Telesca and Alessia Ture

Published
Source
arXiv preprint, posted before peer review
Original
Read it at arXiv
Topics
Machine Learning

Abstract

Population health stratification frameworks, such as the Italian DM77, organize patients by clinical need and care pathways but offer limited guidance on which care changes to prioritize under constrained resources. We present PROMETHEUS (Proactive Resource Optimization through Multi-treatment Effect-based Targeting in Healthcare Environments Using Stratification), a framework that formulates population health stratification as a multi-treatment causal ranking problem. Its objective is to order eligible patient-treatment opportunities by expected incremental benefit rather than obtain perfectly calibrated individual treatment-effect estimates. Each clinically admissible care intensification is compared with maintaining the patient's current pathway. Treatments are learned jointly to produce a globally comparable ranking across patients and care profiles, within domains sharing a reference condition, outcome, follow-up horizon, and benefit scale. This separates clinical need, treatment benefit, and resource-constrained allocation. PROMETHEUS combines doubly robust causal signals with a Siamese neural ranking model and contrastive representation pretraining. The shared representation captures similarities across care transitions, supporting prioritization under capacity constraints. Synthetic experiments and semi-synthetic experiments using real administrative covariates from ASL Benevento evaluate ranking quality, allocation value, robustness, and failure modes. The results support the framework's ability to recover generated benefit orderings and prioritize care opportunities in the evaluated settings. PROMETHEUS provides a preclinical approach to actionable stratification; validation with observed treatment-outcome data is required before clinical use.

The authors’ abstract, as arXiv lists it. arXiv’s listings, abstracts included, are free for anyone to reuse.

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Machine Learning

Get the few papers worth your time in Machine Learning every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics